Digestive enzymes play a vital role in breaking down and absorbing nutrients from foods. They are commonly available as tablets, capsules and powder form and are used to treat various digestive issues like indigestion, gas, bloating, etc. and improve nutrient absorption efficiency. Enzymes supplements are gaining popularity among elderly population as aging slows down natural enzyme production leading to digestion related problems.
The global digestive enzyme market is estimated to be valued at US$ 569 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers for the growth of the digestive enzyme market is the increasing adoption of enzyme supplements among geriatric population. As per the United Nations data, number of people aged 60 years or above is expected to more than double, from 962 million globally in 2017 to 2.1 billion in 2050. With age, the ability of the body to naturally produce digestive enzymes slows down, often resulting in digestive issues like indigestion, bloating and gas. This is increasing the demand for external enzyme supplements in the form of tablets or powders.
Another factor positively impacting the market growth is rising awareness regarding digestive health and benefits of enzyme supplements. Several campaigns by key market players are educating people about role of enzymes in food absorption and how their deficiency can negatively impact health and nutrient uptake. This is encouraging more people to incorporate enzyme supplements in their daily routine to ensure seamless digestion.
SWOT Analysis
Strength: The digestive enzyme market is growing at a substantial rate due to rising awareness about digestive health. Enzymes help improve digestion and aid in better absorption of nutrients. They relieve symptoms of digestive issues like bloating, gas and acid reflux. With increasing gastrointestinal problems, demand for enzymes as a dietary supplement is surging.
Weakness: Overdependency and overdosage of enzyme supplements can hamper natural enzyme production in the body. Excess consumption may also lead to side effects like diarrhea and cramping. Many people are unaware about appropriate dosage levels of different enzymes.
Opportunity: Growth opportunities exist in developing customized enzyme formulations for specific digestive disorders. Enzyme products targeting elderly population also have scope due to age-related decline in digestive capacity. Increasing health consciousness and focus on preventive healthcare will drive the need for quality enzyme supplements.
Threats: Stringent regulatory norms for supplements may increase compliance cost. Launch of low-priced private label supplements by retailers poses pricing pressure. Competition from alternative therapies can impact sales.
Key Takeaways
The global digestive enzyme market is expected to witness high growth due to rising prevalence of gastrointestinal issues. According to estimates, the market was valued at US$ 569 Mn in 2023 and is projected to reach over US$ 1 Bn by 2030 at a CAGR of 11%.
Regional analysis: North America currently dominates the market owing to growing health awareness and focus on preventive care. The Asia Pacific region is likely to provide lucrative opportunities for market players with rising living standards and healthcare expenditure. Countries like China, India and Japan are major producers and consumers of digestive enzyme supplements.
Key players: Key players operating in the digestive enzyme market are National Enzyme Company, Garden of Life LLC, Country Life LLC, Rainbow Light Nutritional System Inc., Food State Inc., Matsun Nutrition, Metagenics, Inc., TwinLab Corporation, Abbott Nutrition, Amway Corporation, Klaire Labs, Zenwise Health LLC, Integrative Therapeutics, LLC, Douglas Labs, Enzymedica Inc., Thorne Research Inc., Pure Encapsulations, LLC, Ortho Molecular Products Inc., Allergy Research Group, Biotics Research Corp. These companies are focused on expanding their product portfolios and investing in R&D to develop innovative delivery forms.
Sign in to leave a comment.